RJH: 4Q21 Earnings Grew YoY but Drop QoQ
Maintain HOLD rating with a TP of Bt33.50, based on 19.14xPE’22E, which is pegged to -1SD of 3-years trading mean. Despite drastic drop in 22E...
291 Views
RJH: Building Back Better 22-23E Through Resilient Core Operation
Yesterday’s analyst meeting came out with a neutral tone. We expect YoY growth in 4Q21 earnings, backed by robust margin upon recovery of cash...
320 Views
Rajthanee Hospital (RJH TB): Q4 Revenue Growth to Decelerate Sequentially as Covid Tailwind Fades
Q4 revenue is expected to slow down q/q as new Covid-19 cases in Thailand is declining steadily. However, non-covid business is recovering. The...
282 Views
RJH: Covid Windfall Largely Priced In
We downgrade our recommendation to HOLD rating, from BUY, with new 2022E target price of Bt40.50, +14% from Bt35.50 previously, derived from...
254 Views
RJH: Resilient Performance Amidst Covid Situation
We maintain BUY rating with new 2022E target price of Bt35.50, from Bt29.00, derived from 30.0xPE, which is -1SD of SET Healthcare sector’s during...
260 Views